Update of CARTITUDE-1: A phase Ib/II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy, in relapsed/refractory multiple myeloma. Primary analysis of the randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results